<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">8590783</PMID>
        <DateCompleted>
            <Year>1996</Year>
            <Month>04</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0940-5429</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>32</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>1995</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Acta diabetologica</Title>
                <ISOAbbreviation>Acta Diabetol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effects of islet cell surface antibodies on the metabolic function of mouse islet B cells in vitro.</ArticleTitle>
            <Pagination>
                <MedlinePgn>153-7</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Immunoglobulin (Ig) fractions from the plasma of a group of newly diagnosed insulin-dependent diabetes mellitus (type 1) patients and set of control subjects were assessed for their effects on isolated mouse islet function. It was found that Igs from type 1 patients caused a significant inhibitory effect on insulin secretion when incubated with mouse islets as compared with controls (25.6 +/- 2.9 pg islet-1 h-1 vs 44.7 +/- 7.7 pg islet-1 h-1, P &lt; 0.05). The plasma samples from which the Igs were obtained were then tested for the presence of antibodies to the mouse islet cell surface (ICSA). Four of the nine patients were positive for ICSA, and plasma samples from eight control subjects were all negative. ICSA-positive samples appeared to have the greatest inhibitory effect on insulin secretion when compared with their respective controls (53.3 +/- 7.0 pg insulin islet -1 min-1 vs 30.9 +/- 3.7 pg insulin islet -1 min-1, (P &lt; 0.05). In contrast, it was also found that ICSA-positive Ig fractions had no significant effect on glucose oxidation when co-incubated with mouse islets as compared with the controls (11.3 +/- 2.3 pmol islet-1 h-1 vs 11.2 +/- 2.9 pmol islet-1 h-1). These studies suggest that Igs from newly diagnosed type 1 patients containing ICSA may impair insulin secretion from isolated mouse islets by mechanisms which do not involve the inhibition of B-cell glucose metabolism.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dronfield</LastName>
                    <ForeName>D M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Unit, Royal London Hospitals NHS Trust, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peakman</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taylor</LastName>
                    <ForeName>K W</ForeName>
                    <Initials>KW</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Acta Diabetol</MedlineTA>
            <NlmUniqueID>9200299</NlmUniqueID>
            <ISSNLinking>0940-5429</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000906">Antibodies</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>IY9XDZ35W2</RegistryNumber>
                <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000078790" MajorTopicYN="N">Insulin Secretion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007515" MajorTopicYN="N">Islets of Langerhans</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008811" MajorTopicYN="N">Mice, Inbred DBA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>1995</Year>
                <Month>10</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>1995</Year>
                <Month>10</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>1995</Year>
                <Month>10</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">8590783</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 1990 Mar 8;322(10):653-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2406597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 1982 May;31(5 Pt 1):459-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6759262</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1978 Aug 24;299(8):375-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">353557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anal Biochem. 1976 Feb;70(2):454-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1267139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1980 Dec 25;303(26):1493-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7001237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 1983 Jun;32(6):520-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6354781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 1984 Aug;33(8):717-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6378696</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fed Proc. 1958 Dec;17(4):1116-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13619782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem J. 1963 Jul;88:137-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13952078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetologia. 1982 Feb;22(2):89-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7037515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1985 Aug 22;313(8):461-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3894969</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 1992 Dec;41(12):1624-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1446804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Exp Med Biol. 1979;119:157-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">91312</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Res Clin Pract. 1988 Jan 7;4(2):127-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3277828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Med. 1991 Oct;23(4):453-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1930942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem J. 1968 Jun;108(1):17-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4297939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocrinology. 1985 Sep;117(3):824-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2862021</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1983 Feb 10;308(6):322-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6337325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 1988 Feb;71(2):353-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3127094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetologia. 1981 Apr;20(4):471-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7016642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1982 Jul;70(1):41-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6123526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Res Clin Pract. 1990 Apr;9(1):7-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2190782</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>